Beam Therapeutics Inc.
BEAM · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$113 | -$102 | -$109 | -$90 |
| Dep. & Amort. | $6 | $6 | $6 | $15 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $24 | $27 | $30 |
| Change in WC | -$7 | $3 | -$25 | -$21 |
| Other Non-Cash | $33 | -$8 | -$1 | -$11 |
| Operating Cash Flow | -$81 | -$76 | -$104 | -$76 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5 | -$3 | -$3 | -$3 |
| Net Acquisitions | -$0 | $0 | $0 | $0 |
| Inv. Purchases | -$176 | -$334 | -$339 | $0 |
| Inv. Sales/Matur. | $246 | $167 | $217 | $129 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $66 | -$170 | -$125 | $126 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $2 | -$1 | $471 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $2 | $2 | $3 |
| Financing Cash Flow | $2 | $1 | $473 | $3 |
| Forex Effect | -$0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$14 | -$246 | $244 | $53 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $282 | $535 | $290 | $237 |
| End Cash | $268 | $289 | $535 | $290 |
| Free Cash Flow | -$86 | -$80 | -$107 | -$79 |